DrugsControl Media Services

News Detail

Dubious drug trials raise serious questions about monitoring and quality control of clinical studies in the country (10-07-2024)

New Delhi, 10 July 2024: Global pharma giant Roche has recently appealed to the Drug Controller General of India (DGCI) to investigate the critical gaps in clinical trials conducted by Indian pharma Cadila Healthcare Ltd (Zydus Cadila) to develop a biosimilar product for treatmen......
View Details

Source : CNBC-TV18

Related News